Vaccine Development

  • Vanderbilt University

    Vanderbilt awarded up to $46M through ARPA-H to develop tools against alphaviruses

    Jens Meiler, Distinguished Research Professor of Chemistry, was named the principal investigator for the project, in cooperation with 14 investigators across eight institutions. The team will work together to use advanced technology, including computational modeling, AI-driven predictions and structural biology, to develop a groundbreaking vaccine against all alphaviruses that offers long-lasting protection. Read More

    Dec 2, 2024

  • Vanderbilt University

    Rational vaccine design

    Understanding immunity generated by smallpox vaccine may hold lessons for COVID-19 vaccine development. Read More

    Sep 22, 2020

  • Artificial intelligence concept showing 0's and 1's flowing into head networked like a circuit board

    New tool may speed antibody, vaccine research

    Antibody discovery and vaccine development research may be on the verge of rapidly expanding with data that previously took decades to acquire, thanks to LIBRA-seq, a new tool developed by Vanderbilt University researchers and their colleagues. Read More

    Dec 12, 2019